International Immunopharmacology

期刊简介：International Immunopharmacology is the primary vehicle for the publication of original research papers pertinent to the overlapping areas of immunology, pharmacology, cytokine biology, immunotherapy, immunopathology and immunotoxicology. Review articles that encompass these subjects are also welcome.The subject material appropriate for submission includes:• Clinical studies employing immunotherapy of any type including the use of: bacterial and chemical agents; thymic hormones, interferon, lymphokines, etc., in transplantation and diseases such as cancer, immunodeficiency, chronic infection and allergic, inflammatory or autoimmune disorders.• Studies on the mechanisms of action of these agents for specific parameters of immune competence as well as the overall clinical state.• Pre-clinical animal studies and in vitro studies on mechanisms of action with immunopotentiators, immunomodulators, immunoadjuvants and other pharmacological agents active on cells participating in immune or allergic responses.• Pharmacological compounds, microbial products and toxicological agents that affect the lymphoid system, and their mechanisms of action.• Agents that activate genes or modify transcription and translation within the immune response.• Substances activated, generated, or released through immunologic or related pathways that are pharmacologically active.• Production, function and regulation of cytokines and their receptors.• Classical pharmacological studies on the effects of chemokines and bioactive factors released during immunological reactions.

【译文】国际免疫药理学是发表与免疫学、药理学、细胞因子生物学、免疫治疗、免疫病理学和免疫毒理学重叠领域的原创研究论文的主要途径。也欢迎涵盖这些主题的综述文章。适合提交的主题材料包括：• 采用任何类型的免疫治疗（包括使用：细菌和化学制剂；胸腺激素、干扰素、淋巴因子等）的临床研究，包括移植和癌症、免疫缺陷、慢性感染以及过敏、炎症或自身免疫性疾病等疾病。• 研究这些制剂的作用机制，包括对免疫能力特定参数以及整体临床状态的影响。• 关于免疫增强剂、免疫调节剂、免疫佐剂和其他对参与免疫或过敏反应的细胞具有活性的药理剂的药理作用机制的前临床动物研究和体外研究。• 影响淋巴系统的药理化合物、微生物产物和毒理学剂及其作用机制。• 激活基因或改变免疫反应中转录和翻译的制剂。• 通过免疫或相关途径激活、生成或释放的具有药理活性的物质。• 细胞因子及其受体的生产、功能和调节。• 关于免疫反应期间释放的趋化因子和生物活性因子的经典药理学研究。